Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

TORONTO, June 20, 2019 /CNW/ -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, reported today that the U.S. Food and Drug Administration has notified the company that it may proceed with its clinical investigation of EB01, a novel sPLA2 inhibitor, which Edesa... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019
Related companies:  Edesa Biotech Inc.

Orion Biotechnology Reports Additional Positive Preclinical Data for OB-002 in the Treatment of Colorectal Cancer

OTTAWA, Ontario, June 20, 2019 /PRNewswire/ -- Orion Biotechnology Canada Ltd., today announced new preclinical data evaluating the efficacy of OB-002 (5P12-RANTES) in colorectal cancer. BALB/c mice were inoculated subcutaneously with the CT-26 colorectal cancer cell line. Seven days after inoculation,... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019
Related companies:  Orion Canada Inc.

AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019

TeraRecon Receives First-of-Kind FDA Determination

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Terarecon, Inc.

Glenmark Pharmaceuticals Receives Tentative ANDA Approval for Clindamycin Phosphate Foam, 1%

MUMBAI, June 20, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2019

Abris to Acquire Dentotal Protect, the Leading Distributor of Dental Products in Romania

WARSAW, Poland, June 20, 2019 /PRNewswire/ -- Abris Capital Partners, the Central & Eastern European private equity fund manager, has signed an agreement to acquire Dentotal Protect, the leading distributor of dental consumables, instruments and equipment in Romania, from the Dogariu... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019

OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria

STOCKHOLM, June 20, 2019 /PRNewswire/ -- OxThera AB, a biopharmaceutical company dedicated to improve the lives of people living with Primary Hyperoxaluria, today announced that the first patients in a Phase 3 study of Oxabact(®) have completed the study and transitioned to an open-label extension... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019

LifeFlow Showcased at Premier Inc.'s Annual Breakthroughs Conference

DURHAM, N.C., June 20, 2019 /PRNewswire/ -- LifeFlow, a simple new device for rapid delivery of a targeted fluid bolus, is one of the medical innovations that was showcased in front of thousands of healthcare providers at Premier Inc.'s 2019 Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019
Related companies:  410 Medical Inc.

Atreca Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Atreca, Inc.

Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Genocea Biosciences, Inc.

Addex Shareholders Approve All Resolutions at Annual General Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Addex Therapeutics S.A.

Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK” clinical trial design and rationale

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Innate Pharma S.A.

Akero Therapeutics Announces Pricing of Initial Public Offering

SAN FRANCISCO, June 19, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (NASDAQ: AKRO), a clinical-stage biotechnology company developing transformational treatments for people with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced the pricing of its initial... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019
Related companies:  Akero Therapeutics, Inc.

Regal And ADOC Medical Groups Announce Contract With MemorialCare Saddleback Medical Center

LAGUNA HILLS, Calif., June 19, 2019 /PRNewswire/ -- Regal and ADOC Medical Groups announce that it has entered into an in-network contract with MemorialCare Saddleback Medical Center to provide comprehensive medical care to its members of all ages in Laguna Hills and surrounding communities.... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019

Cryoport Announces Pricing of Public Offering of Common Stock

IRVINE, Calif., June 19, 2019 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) (Nasdaq: CYRXW) ("Cryoport" or the "Company") today announced the pricing of its underwritten public offering of an aggregate of 3,750,000 newly issued shares of common stock at a price of $17.00 per share. In addition,... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019
Related companies:  Cryoport Systems

New IDSAF and NIA research grants will speed Alzheimer's microbe hunt, says Dr. Leslie Norins of Alzheimer's Germ Quest, Inc.

NAPLES, Fla., June 19, 2019 /PRNewswire/ -- The half-million dollars in Alzheimer's disease (AD) research grants recently Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019

Scholar Rock Announces Pricing of Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Scholar Rock, Inc.

Cronos Group Inc. Announces Results of Vote for Election of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Cronos Group Inc.

World Endometriosis Markets, 2014-2019 & 2019-2026: Key Pipeline and Marketed Drugs, Clinical Trials, Upcoming and Regulatory Events, Patent Information, Licensing and Acquisition Deals

DUBLIN, June 19, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019

Global Hidradenitis Suppurativa Market Report 2019 - Abbott has the Highest Number of Completed Clinical Trials for HS, with Two Trials

DUBLIN, June 19, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 20 Jun 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑